🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AVX
$AVXL
🔒 US EquitiesAnavex Life Sciences Corp.
AVG HISTORICAL GAP
+2.02%
MAX GAP RECORD
+8.36%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AVXL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AVXL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 24, 2026 Earnings Release 2026-11-24 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 25, 2026 Earnings Release 2026-08-25 (BEFORE OPEN) |
+8.36%
|
| Feb 09, 2026 Earnings Release 2026-02-09 (BEFORE OPEN) |
+2.44%
|
| Nov 25, 2025 Earnings Release 2025-11-25 (BEFORE OPEN) |
+6.82%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN) |
-0.26%
|
| May 13, 2025 Earnings Release 2025-05-13 (BEFORE OPEN) |
+0.94%
|
| Feb 12, 2025 Earnings Release 2025-02-12 (BEFORE OPEN) |
-2.90%
|
| Dec 23, 2024 Earnings Release 2024-12-23 (BEFORE OPEN) |
+3.36%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.3%
Bullish Gaps (8)
Bearish Gaps (3)
Neutral / Flat (2)
📖 Intelligence Summary
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine),…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗